Search Results - "Laskow, David A"

Surgical resident perspective on deceased donor organ procurement by Osband, Adena J., M.D, Laskow, David A., M.D

“…Abstract Background Deceased donor organ procurement provides unparalleled opportunity for surgical residents with extensive surgical exposure. We hypothesize…”
Get full text

Virtual microscopy improves sharing of deceased donor kidneys by Osband, Adena J., M.D, Fyfe, Billie, M.D, Laskow, David A., M.D

“…Abstract Background Donor kidney biopsies used for offer evaluation may lengthen cold ischemia time. Our organ procurement organization began processing wedge…”
Get full text

Morbid Obesity Is Not an Independent Predictor of Graft Failure or Patient Mortality After Kidney Transplantation by Pieloch, Daniel, MS, RD, Dombrovskiy, Viktor, MD, PhD, MPH, Osband, Adena J., MD, Lebowitz, Jonathan, MD, Laskow, David A., MD

“…Objective Obesity is often an absolute contraindication to kidney transplant, but an internal analysis of our center's recipients suggests that not all obese…”
Get full text

The Impact of Morbid Obesity on Hospital Length of Stay in Kidney Transplant Recipients by Pieloch, Daniel, MS, RD, Mann, Richard, MD, Dombrovskiy, Viktor, MD, PhD, MPH, DebRoy, Meelie, MD, Osband, Adena J., MD, Mondal, Zahidul, MD, Fernandez, Sonalis, MD, Laskow, David A., MD

“…Objectives Obesity is often associated with higher hospital costs because of longer length of stay (LOS) but this has not been well studied in the kidney…”
Get full text

Rapid Loss of Vertebral Mineral Density after Renal Transplantation by Julian, Bruce A, Laskow, David A, Dubovsky, Eva V, Dubovsky, Jiri, Curtis, John J, Quarles, L. Darryl

“…RENAL transplantation corrects many of the disturbances of calcium and phosphorus metabolism that lead to renal osteodystrophy in patients with chronic renal…”
Get full text

The Kidney Transplant Morbidity Index (KTMI): A Simple Prognostic Tool to Help Determine Outcome Risk in Kidney Transplant Candidates by Pieloch, Daniel, Dombrovskiy, Viktor, Osband, Adena J., DebRoy, Meelie, Mann, Richard A., Fernandez, Sonalis, Mondal, Zahidul, Laskow, David A.

“…Background The Kidney Transplant Morbidity Index (KTMI) is a novel prognostic morbidity index to help determine the impact that pretransplant comorbid…”
Get full text

Sirolimus lowers myeloperoxidase and p-ANCA titers in a pediatric patient before kidney transplantation by Constantinescu, Alex R., Liang, Michael, Laskow, David A.

“…We report the case of a child with microscopic polyangiitis (myeloperoxidase-antineutrophil cytoplasmic antibody [p-ANCA]-positive vasculitis) whose disease…”
Get full text

Dialysis access failure: an indication for immediate kidney transplantation by Laskow, David A, Ahsan, Nasimul

“…In the United States, presently there are more than 50,000 patients with end-stage renal disease (ESRD) awaiting a cadaveric kidney and each year less than a…”
Get full text

The role of tacrolimus in adult kidney transplantation: a review by Laskow, D A, Neylan, 3rd, J F, Shapiro, R S, Pirsch, J D, Vergne-Marini, P J, Tomlanovich, S J

“…The use of tacrolimus (FK506) in adult kidney-transplant recipients has been the subject of a number of single- and multi-center studies. This review article…”
Get more information

SUN-LB085 Complicated Hungry Bone Syndrome Due to Tertiary Hyperparathyroidism in a Patient with Kidney Transplant: A Case to Remember by Jimenez-Zuluaga, Jose, Caputi, Rafael, Luo, Hongxiu, Laskow, David A.

“…Introduction: Hyperparathyroidism with parathyroid hyperplasia can result from prolonged stimulation of parathyroid glands in chronic kidney disease which may…”
Get full text

Cyclosporine-induced changes in glomerular filtration rate and urea excretion by Laskow, D A, Curtis, J J, Luke, R G, Julian, B A, Jones, P, Deierhoi, M H, Barber, W H, Diethelm, A G

“…Cyclosporine is the mainstay of many immunosuppressant protocols, but confers a significant risk of nephrotoxicity. We sought to clarify the effects of…”
Get more information

An open-label, concentration-ranging trial of FK506 in primary kidney transplantation : A report of the United States Multicenter FK506 Kidney Transplant group by LASKOW, D. A, VINCENTI, F, NEYLAN, J. F, MENDEZ, R, MATAS, A. J

“…This was a multicenter, open-label, concentration-ranging trial of FK506 and cyclosporine in 120 patients undergoing primary cadaveric kidney transplant…”
Get full text

LONG-TERM RESULTS WITH PROGRAF INDICATE PROLONG HALF-LIFE AND IMPROVED RENAL FUNCTION IN CADAVERIC RENAL TRANSPLANTS by Laskow, David A.

Get full text

Cardiovascular Risk Factors In Renal Transplant Recipients: 2-3 Year Results From The FK506 Multicenter, Randomized Comparative Trial by Laskow, David A.

Get full text

Cardiovascular Risk Factors In Renal Transplant Recipients: 2-3 Year Results From The FK506 Multicenter, Randomized Comparative Trial by Laskow, David A.

Get full text

Editorials: Dialysis Access Failure: An Indication for Immediate Kidney Transplantation by Laskow, David A., Ahsan, Nasimul

“…In the United States, presently there are more than 50,000 patients with end‐stage renal disease (ESRD) awaiting a cadaveric kidney and each year less than a…”
Get full text

Transforming growth factor-β levels in human allograft chronic fibrosis correlate with rate of decline in renal function by CUHACI, B, KUMAR, M. S. A, STURGILL, B. C, PANKEWYCZ, O. G, BLOOM, R. D, PRATT, B, HAUSSMAN, G, LASKOW, D. A, ALIDOOST, M, GROTKOWSKI, C, CAHILL, K, BUTANI, L

“…Long-term renal transplant function is limited primarily by a progressive scarring process loosely termed "chronic rejection, chronic allograft nephropathy, or…”
Get full text

One-year follow-up of an open-label trial of FK506 for primary kidney transplantation : A report of the U.S. Multicenter FK506 Kidney Transplant Group by VINCENTI, F, LASKOW, D. A, NEYLAN, J. F, MENDEZ, R, MATAS, A. J

“…Patients undergoing primary cadaveric kidney transplantation were followed for 1 year as part of a phase II, multicenter, open-label concentration-ranging…”
Get full text

Quiz page July 2009. Fever and neutropenia following simultaneous pancreas-kidney transplantation. Graft-versus-host disease by Osband, Adena J, Laskow, David A, Berkowicz, Teresa, Mann, Richard A

Get full text

Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients by Barber, W H, Mankin, J A, Laskow, D A, Deierhoi, M H, Julian, B A, Curtis, J J, Diethelm, A G

“…Experimental studies have shown that antilymphocyte globulin combined with transfusion of donor-specific bone marrow cells can induce partial tolerance to…”
Get more information